-
-
-
-
-
-
-
Anebulo Pharmaceuticals (ANEB) PT Lowered to $3 at Benchmark
-
-
-
-
-
-
-
Benchmark Reiterates Speculative Buy Rating on Anebulo Pharmaceuticals (ANEB)
-
-
-
-
-
-
-
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
-
-
-
-
-
-
-
Anebulo Pharmaceuticals (ANEB) PT Lowered to $10 at Benchmark
-
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

